- $1.18bn
- $1.09bn
- $23.07m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.78 | ||
| Price to Tang. Book | 5.95 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 51.06 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -51.25% | ||
| Return on Equity | -89.04% | ||
| Operating Margin | -1051.7% | ||
Financial Summary
| Year End 29th Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | 6.2 | 7.64 | 23.07 | 34.49 | 139.47 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Enovix Corporation is a global high-performance battery company. The Company designs, develops, manufactures, and commercializes lithium-ion (Li-ion) battery cells that increase the amount of energy density and storage capacity relative to conventional battery cells. In addition to designing its batteries, it also develops the advanced manufacturing processes needed to produce its batteries in high volume. It targets a smaller group of large customers that require custom cells. Its technology roadmap is built around a structured progression of battery nodes, with each new generation, such as the EX-1M, EX-2M, EX-3M and so on. The Company, through Routejade, Inc. (Routejade), supplies batteries for wearables, medical devices, headsets, activity trackers, and industrial equipment. Routejade offers product categories, including PD series, FLPB and ASDB series, and SLPB series. The PD series consists of rechargeable coin cells commonly used in healthcare and IoT applications.
Directors
- Last Annual
- December 29th, 2024
- Last Interim
- December 29th, 2024
- Incorporated
- September 23rd, 2020
- Public Since
- December 4th, 2020
- No. of Shareholders
- 56
- No. of Employees
- 570
- Sector
- Machinery, Equipment & Components
- Industry
- Industrials
- Exchange
NASDAQ Global Select Market- Shares in Issue
- 191,273,833
- Address
- 3501 W. Warren Avenue, FREMONT, 94538
- Web
- https://www.enovix.com/
- Phone
- +1 6507222555
- Auditors
- Deloitte & Touche LLP
Upcoming Events for ENVX
Q1 2025 Enovix Corp Earnings Call
Enovix Corp at JPMorgan Global Technology, Media and Communications Conference
Enovix Corp at William Blair Growth Stock Conference
Enovix Corp Annual Shareholders Meeting
Q2 2025 Enovix Corp Earnings Release
Similar to ENVX
AAON
NASDAQ Global Select Market
Advanced Energy Industries
NASDAQ Global Select Market
American Superconductor
NASDAQ Global Select Market
Astec Industries
NASDAQ Global Select Market
Cognex
NASDAQ Global Select Market
FAQ
What is the Enovix share price?
As of Today at 20:27 UTC, shares in Enovix are trading at $6.16. This share price information is delayed by 15 minutes.
How has the Enovix share price performed this year?
Shares in Enovix last closed at $6.16 and the price had moved by -7.09% over the past 365 days. In terms of relative price strength the Enovix share price has underperformed the S&P500 Index by -12.64% over the past year.
What are the analyst and broker recommendations for Enovix?
The overall consensus recommendation for Enovix is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Enovix dividend yield?
Enovix does not currently pay a dividend.
Does Enovix pay a dividend?
Enovix does not currently pay a dividend.
When does Enovix next pay dividends?
Enovix does not currently pay a dividend.
How do I buy Enovix shares?
To buy shares in Enovix you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Enovix?
As of the previous close price of $6.16, shares in Enovix had a market capitalisation of $1.18bn.
Where are Enovix shares listed?
Here are the trading details for Enovix:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: ENVX
What kind of share is Enovix?
Based on an overall assessment of its quality, value and momentum Enovix is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Enovix share price forecast for 2025?
The analyst consensus target price for shares in Enovix is $26.25. That is 326.14% above the last closing price of $6.16.
Analysts covering Enovix currently have a consensus Earnings Per Share (EPS) forecast of -$0.71 for the next financial year.
Find out moreWhat is the trend in the Enovix share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Enovix. Over the past six months, its share price has underperformed the S&P500 Index by -40.38%.
As of the last closing price of $6.16, shares in Enovix were trading -40.73% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Enovix PE Ratio?
The Enovix PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $6.16.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Enovix?
We do not have data on Enovix's directors